Tuberc Respir Dis.  2000 Aug;49(2):189-197. 10.4046/trd.2000.49.2.189.

TIMP-2 gene transfer via adenovirus inhibits the invasion of lung cancer cell

Abstract

BACKGROUND
Tissue inhibitor of metalloproteinase is a natural inhibitor that counteracts proteolytic enzymes essential to the invasion of cancer cell. Whether or not TIMP-2 gene transfer via adenovirus could inhibit the invasion of lung cancer cell in vitro was evaluated for the future purpose of gene therapy against lung cancer.
METHODS
Recombinant adenvirus-TIMP-2(Ad-TIMP-2) was generated by homologeous recombination after pACCMV-TIMP-2 and pJM17 were cotransfected into 293 cell by standard calcium phosphate coprecipitate mathod. Calu-6, one of the most invasive lung cancer cells, was transduced with Ad-TIMP-2 or Ad-β-gal. An-chorage-independent growth and invasiveness were assessed by soft agar clonogenicity assay and invasion assay using two-chamber, well divided by matrigel.
RESULTS
Ad-TIMP-2 transduced calu-6 cells produced bilolgically active TIMP-2 more than 50 times more than parental calu-6. TIMP-2 gene transfer did not suppress the in vitro tumorgenicity. However, two chamber well assay revealed that Ad-TIMP-2 transduction reduced the invasiveness of calu-6 efficiently (12% compared with parental cell) even at low 10moi.
CONCLUSION
Even though TIMP-2 gene transfer did not inhibit in vitr tumorigenicity, it did inhibit invasion of lung cancer cell in vitro. The inhibition of invasion by Ad-TIMP-2 may be a useful strategy for the treatment of lung cancer.

Keyword

TIMP-2; Gene transfer; Lung cancer; Invasion

MeSH Terms

Adenoviridae*
Agar
Calcium
Genetic Therapy
Humans
Lung Neoplasms*
Lung*
Parents
Peptide Hydrolases
Recombination, Genetic
Tissue Inhibitor of Metalloproteinase-2*
Agar
Calcium
Peptide Hydrolases
Tissue Inhibitor of Metalloproteinase-2
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr